These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

659 related items for PubMed ID: 12097371

  • 1. CD94/NKG2 expression does not inhibit cytotoxic function of lymphocytic choriomeningitis virus-specific CD8+ T cells.
    Miller JD, Peters M, Oran AE, Beresford GW, Harrington L, Boss JM, Altman JD.
    J Immunol; 2002 Jul 15; 169(2):693-701. PubMed ID: 12097371
    [Abstract] [Full Text] [Related]

  • 2. Expression of Ly49E and CD94/NKG2 on fetal and adult NK cells.
    Van Beneden K, Stevenaert F, De Creus A, Debacker V, De Boever J, Plum J, Leclercq G.
    J Immunol; 2001 Apr 01; 166(7):4302-11. PubMed ID: 11254682
    [Abstract] [Full Text] [Related]

  • 3. Expression of inhibitory receptors Ly49E and CD94/NKG2 on fetal thymic and adult epidermal TCR V gamma 3 lymphocytes.
    Van Beneden K, De Creus A, Stevenaert F, Debacker V, Plum J, Leclercq G.
    J Immunol; 2002 Apr 01; 168(7):3295-302. PubMed ID: 11907085
    [Abstract] [Full Text] [Related]

  • 4. Mouse CD94 participates in Qa-1-mediated self recognition by NK cells and delivers inhibitory signals independent of Ly-49.
    Toyama-Sorimachi N, Taguchi Y, Yagita H, Kitamura F, Kawasaki A, Koyasu S, Karasuyama H.
    J Immunol; 2001 Mar 15; 166(6):3771-9. PubMed ID: 11238619
    [Abstract] [Full Text] [Related]

  • 5. Viral and bacterial infections induce expression of multiple NK cell receptors in responding CD8(+) T cells.
    McMahon CW, Zajac AJ, Jamieson AM, Corral L, Hammer GE, Ahmed R, Raulet DH.
    J Immunol; 2002 Aug 01; 169(3):1444-52. PubMed ID: 12133970
    [Abstract] [Full Text] [Related]

  • 6. Interleukin-15-induced maturation of human natural killer cells from early thymic precursors: selective expression of CD94/NKG2-A as the only HLA class I-specific inhibitory receptor.
    Mingari MC, Vitale C, Cantoni C, Bellomo R, Ponte M, Schiavetti F, Bertone S, Moretta A, Moretta L.
    Eur J Immunol; 1997 Jun 01; 27(6):1374-80. PubMed ID: 9209487
    [Abstract] [Full Text] [Related]

  • 7. Orderly and nonstochastic acquisition of CD94/NKG2 receptors by developing NK cells derived from embryonic stem cells in vitro.
    Lian RH, Maeda M, Lohwasser S, Delcommenne M, Nakano T, Vance RE, Raulet DH, Takei F.
    J Immunol; 2002 May 15; 168(10):4980-7. PubMed ID: 11994449
    [Abstract] [Full Text] [Related]

  • 8. Preferential survival of CD8 T and NK cells expressing high levels of CD94.
    Gunturi A, Berg RE, Forman J.
    J Immunol; 2003 Feb 15; 170(4):1737-45. PubMed ID: 12574337
    [Abstract] [Full Text] [Related]

  • 9. CD94/NKG2 inhibitory receptor complex modulates both anti-viral and anti-tumoral responses of polyclonal phosphoantigen-reactive V gamma 9V delta 2 T lymphocytes.
    Poccia F, Cipriani B, Vendetti S, Colizzi V, Poquet Y, Battistini L, López-Botet M, Fournié JJ, Gougeon ML.
    J Immunol; 1997 Dec 15; 159(12):6009-17. PubMed ID: 9550399
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. The non-classical MHC class I molecule Qa-1(b) inhibits classical MHC class I-restricted cytotoxicity of cytotoxic T lymphocytes.
    Lohwasser S, Kubota A, Salcedo M, Lian RH, Takei F.
    Int Immunol; 2001 Mar 15; 13(3):321-7. PubMed ID: 11222501
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Impaired anti-viral T cell responses due to expression of the Ly49A inhibitory receptor.
    Zajac AJ, Vance RE, Held W, Sourdive DJ, Altman JD, Raulet DH, Ahmed R.
    J Immunol; 1999 Nov 15; 163(10):5526-34. PubMed ID: 10553080
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Kinetics and peptide dependency of the binding of the inhibitory NK receptor CD94/NKG2-A and the activating receptor CD94/NKG2-C to HLA-E.
    Valés-Gómez M, Reyburn HT, Erskine RA, López-Botet M, Strominger JL.
    EMBO J; 1999 Aug 02; 18(15):4250-60. PubMed ID: 10428963
    [Abstract] [Full Text] [Related]

  • 17. Differential expression of inhibitory and activating CD94/NKG2 receptors on NK cell clones.
    Brostjan C, Bellón T, Sobanov Y, López-Botet M, Hofer E.
    J Immunol Methods; 2002 Jun 01; 264(1-2):109-19. PubMed ID: 12191515
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Triggering of effector functions on a CD8+ T cell clone upon the aggregation of an activatory CD94/kp39 heterodimer.
    Bellón T, Heredia AB, Llano M, Minguela A, Rodriguez A, López-Botet M, Aparicio P.
    J Immunol; 1999 Apr 01; 162(7):3996-4002. PubMed ID: 10201920
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 33.